7th Annual Jefferson Infertility Counseling Conference
Andrea Mechanick Braverman, PhD (Director)
Clinical Professor of Obstetrics & Gynecology, Clinical Associate Professor of Psychiatry & Behavioral Medicine
Thomas Jefferson University
Dr. Braverman is a Clinical Associate Professor with a joint appointment in the Department of Obstetrics and Gynecology and Psychiatry and Behavioral Medicine at Thomas Jefferson University. Dr. Braverman is the Associate Director for the Educational Core for OB/Gyn. She is a health psychologist with a specialty in medical health management, infertility counseling, and third party reproduction issues. She received her M.A., M.S. and Ph.D. in psychology from the University of Pennsylvania. Dr. Braverman has lectured internationally on treatment issues and reproductive medicine before medical and patient audiences. Dr. Braverman has conducted research and published numerous articles in medical journals about the psychological aspects of infertility, attitudes of parents of children born with the use of ART, issues involved in the decision to end treatment, and psychological issues involved in using third-party donors. Dr. Braverman received the Timothy Jeffries Memorial award in 2011 for outstanding contributions as a health psychologist from the American Psychological Association. She is the past president of the North American Society for Psychosocial Obstetrics and Gynecology and past chairperson of the Mental Health Professional Group of the American Society for Reproductive Medicine (ASRM).
Helen L. Coons, PhD, ABPP
Department of Psychiatry
University of Colorado School of Medicine
Helen L. Coons, Ph.D., ABPP has over 25 years of professional experience with women and families coping with physical conditions, collaborating with health care providers and consulting on women’s health and mental health care at the national level. She received her Ph.D. in Clinical Psychology from Temple University after interning in Medical Psychology at the Duke University Medical Center, and completed the DHHS Primary Health Care Policy Fellowship in 2005.
Dr. Coons is a board certified clinical health psychologist, and Faculty Coordinator, Women’s Behavioral Health, Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado. She oversees the development, implementation and evaluation of women’s behavioral health and wellness programs in the Department of Psychiatry and within the women’s health service line. Dr. Coons was the President and Clinical Director of Women’s Mental Health Associates and Health Psychology Solutions in Denver and Boulder from 2000-2018. During that time, her practice rotated to women’s multispecialty, primary care, obstetrics and gynecology, reproductive endocrinology, urogynecology, oncology and pelvic pain settings. She routinely provides evidenced based care to women coping with fertility challenges and decisions, pregnancy complications and loss, neonatal complications, perinatal mood disorders, sleep disorders, trauma across the life span, pelvic pain, bladder and sexual conditions, breast, gynecologic and other cancers and a host of additional issues seen in Ob/Gyn settings.
Dr. Coons is a dynamic speaker known at the national level for presentations to health care providers and community audiences on women’s heath and mental health topics as well as psychosocial oncology. She is also a highly experienced content expert for print and online media. In addition, Dr. Coons enjoys consulting for Federal organizations such as SAMHSA and NIH’s NIDDK as well as pharmaceutical companies and A fellow of the American Psychological Association, Dr. Coons was the founding chair of the APA Leadership Institute for Women in Psychology from 2007-2014. In addition, she served on the APA Board of Directors from 2016-2018.
Susan L. Crockin, JD (Co-Director)
Principal, Crockin Law & Policy Group, PLLC, Sr. Scholar, O’Neil Institute for National & Global Health Law, Georgetown Law Center
Crockin Law Firm, Georgetown Law Center
SUSAN CROCKIN, JD, has been practicing assisted reproductive technology (ART) law since 1988, after started one of the 1st US legal practices devoted exclusively to ART and adoption law. She now teaches “ART Law” at Georgetown Law Center, writes extensively on the legal, ethical and policy aspects of the ARTS and has expanded her private practice to include medical and 3rd party ART programs, sperm and egg banks. Susan is an adjunct professor and scholar at Georgetown Law Center’s O’Neill Institute for National & Global Health Law and an affiliate faculty at Georgetown’s Kennedy Institute of Ethics, where she is working on multi-disciplinary ARTs endeavors.   Susan created ASRM’s “Legally Speaking” column in 1990, and has authored numerous journal articles, chapters, and books; she co-authored her most recent book, “Legal Conceptions: Evolving Law and Policy of the ARTs,” w/the late Dr. Howard Jones in 2010. Susan was a founding member of both ASRM’s Legal Professional Group and the American Academy of Reproductive Technology Attorneys; she is a former board member of national and Massachusetts RESOLVE; and a current member of SART’s Model Consent Committee.
Kathryn J. Go, PhD, HCLD (ABB) Ph.D. HCLD
Director, Embryology Laboratory, Managing Director, Embryology
Boston IVF
Kathryn J. Go, PhD, HCLD is the clinical laboratory director at ReproSource Fertility Diagnostics and the director of the embryology laboratory at Boston IVF – the Maine Center. Dr. Go was, for 11 years, the Scientific and Laboratory Director at IVF New England (formerly, the Reproductive Science Center of New England) and for 21 years before that, the Laboratory Director at Pennsylvania Reproductive Associates. Dr. Go holds a PhD in molecular biology from the University of Pennsylvania and has been a laboratory director for the assisted reproductive technologies since 1984. Dr. Go has been active in both SART and the ASRM, having served as a member of the SART executive council through several terms, consultant to the FDA, course chairman and faculty for several ASRM and New England Fertility Society postgraduate courses, and chairman of the Reproductive Biology Professional group of the ASRM. Dr. Go has also been president of the New England Fertility Society, and was a lecturer at the Medical College of Pennsylvania and on the faculties of the University of Pennsylvania, Thomas Jefferson University, the Experimental College of Tufts University and the University of Massachusetts. Dr. Go is the author of many peer-reviewed research articles, abstracts and book chapters, and was a specialty editor for Case Reports in Women’s Health. With a hope and vision for the future, one of Dr. Go’s primary interests is the best preparation of the next generations of clinical embryologists.
Jacqueline Gutmann, MD
Clinical Associate Professor
Thomas Jefferson University
A graduate of Yale University School of Medicine, Dr. Gutmann completed her residency in Obstetrics and Gynecology as well as a fellowship in Reproductive Endocrinology and Infertility at Yale-New Haven Hospital. Dr. Gutmann is Clinical Associate Professor of Obstetrics and Gynecology at Thomas Jefferson University and a physician at RMA of Philadelphia.  Dr. Gutmann has published numerous articles and has lectured extensively on infertility, assisted reproductive technology, LGBT family building and complementary and alternative medicine in infertility.  She has held numerous leadership positions in local and national professional organizations and is on the medical advisory boards of several patient advocacy groups. 
William D. Petok, PhD (Co-Director)
Clinical Associate Professor of Obstetrics & Gynecology, Licensed Psychologist
Thomas Jefferson University, Independent Practice
In addition to a full time clinical practice in psychology, Bill Petok is a Clinical Associate Professor of Obstetrics and Gynecology at Thomas Jefferson University. He earned his doctorate at the University of Maryland, College Park, in 1978. Dr. Petok is currently a board member of the Path 2 Parenthood (formerly the American Fertility Association) and a member of the Executive Council of the Society for Assisted Reproductive Technology. He is a past chair of the Mental Health Professional Group of the American Society for Reproductive Medicine.  He regularly speaks on sexuality and assisted reproductive technologies at Professional meetings. His publications include book chapters on Infertility Counseling, Sexuality and Gender Based Differences as well as journal articles on Male Factor Infertility, the interface of religion and sexuality and the treatment of sexual dysfunctions.
Jeff Wahl
Jeffrey R. Wahl, Co. L.P.A.

Jeffrey Wahl is a 1980 graduate of Franklin & Marshall College (A.B., Government) and the Case Western Reserve University School of Law (J.D., 1983), where he was a Law Review editor. He is a recognized expert on the use of technology in healthcare to improve outcomes, reduce risk and liability, and improve communications between physicians and patients. He speaks on a wide variety of topics in medical risk management, the use of innovative technologies in healthcare, and other topics including patient safety. He is a frequent lecturer and teacher at law schools, medical schools, academic medical centers and to other prominent groups including clinical research professionals. These include the Cleveland Clinic, University of Cincinnati School of Medicine, University Hospitals Case Medical Center, the bioethics program at the University of Virginia, Wake Forest Law School, Northwestern University’s graduate program in health communications, national anesthesia and surgery conferences, and others. In 2017, Mr. Wahl taught a class at UVA Law School on administrative rulemaking at NIH with Dr. Carrie Wolinetz, NIH’s Associate Director of Science Policy. He teaches regularly in the pediatric anesthesia fellowship program at Children’s Hospital of UPMC. Some of his more notable lectures to medical practitioners include: The Phantom of the Opera-ting Room; What Suzanne Somers Can Teach You About Being an Expert Witness; Recent Trends in Apology Legislation in Healthcare; and Scientific (Dis)honesty, Clinical Research and Retractions. In September, he addressed the annual meeting of the International Health Facility Diversion Association (IHFDA) in Orlando, with a talk entitled From the Operating Room to the Court Room: A Case of Drug Diversion.

In May 2020, he will speak at the Thomas Jefferson University Infertility Counseling Conference on legal issues relating to the 2018 University Hospitals fertility clinic catastrophic tank failure which destroyed 4,000 embryos and human eggs belonging to almost 1000 women and couples, as a member of the plaintiffs’ executive committee and expert witness lead, with a talk entitled: Mr. Wahl was the only non-physician member of the editorial board of a hematology/oncology publication and has been published and quoted in other healthcare journals on various topics including HIPAA, risk management, patient safety, physician-patient communications, paper and electronic charting, hospital and pharmaceutical company litigation, and others. 

He is co-author of a chapter on legal issues in pediatric anesthesia in the 9th edition of Smith’s Anesthesia for Children and Infants, the pre-eminent text on the subject. He currently is writing a chapter for the 10th edition, which will focus on the legal implications of the use of opioids with minors, including special informed consent and other complex issues. He chaired the medical advisory board of a Pittsburgh / Silicon Valley healthcare technology company (Invivodata, subsequently acquired by ERT) which developed patient-focused digital data capture applications for FDA drug and device trials and was involved in the early development of electronic prescribing.  Mr. Wahl has been a consultant on risk management, medical-legal and marketing/messaging issues for medical/surgical instrument and technology companies. He also is the founder of a digital informed consent application company which partners with a peer venture founded by an Israeli surgeon/attorney, providing improved literate consent processes for clinical and clinical research (IRB) applications.

He has practiced medical risk management / medical malpractice litigation for more than thirty years in multiple state and federal jurisdictions. He was lead counsel in litigation involving a national group of plastic surgery clinics regarding its false and deceptive sales, marketing and deficient informed consent practices. He has handled legal matters in almost all medical specialties and practices, in healthcare venues from small practices to nationally recognized departments at major academic medical centers. He has worked with expert physicians from all the top 20 hospitals in the nation. Mr. Wahl is one of the founders, directors and president of MIDAS Healthcare Technologies, Inc., a venture developing unique pharmaceutical industry products and systems to prevent diversion of and accidental exposure to controlled substances in the institutional healthcare delivery environment as well as in the outpatient/retail world.  He has assembled an extraordinary team including former high-ranking military officials, world-class physician and science leaders, experts in pharmacy and pharmaceuticals, a former Secretary of Homeland Security, and others. In March 2019, Mr. Wahl was a panelist at the Milken Institute Center for Public Health Conference on Digital Health Innovations Combatting the Opioid Crisis, representing MIDAS.  His work with Milken will continue at its Future of Health Summit in October 2019.